BCM
NVRO

Bridgeway Capital Management’s NEVRO CORP. NVRO Stock Holding History

Bridgeway Capital Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-211,500
Closed -$787K – 1266
2024
Q4 		$787K Sell
211,500
-35,500
-14% -$164K 0.02% 719
2024
Q3 		$1.38M Buy
+247,000
New +$1.73M 0.03% 603

Other funds holding NVRO

BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Bridgeway Capital Management's NVRO Position: Q1 2025 in Review

Bridgeway Capital Management sold out of NEVRO CORP. (NVRO) in Q1 2025, closing a stake of 211,500 shares — an estimated $787K sold.

Bridgeway Capital Management first reported a position in NVRO in Q3 2024 and held it in 2 quarters. The position peaked at $1.38M in Q3 2024. 126 funds tracked by Wall St. Rank hold NVRO as of Q1 2025.

  • Bridgeway Capital Management reported no remaining NEVRO CORP. position as of Q1 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 211,500 NEVRO CORP. shares in Q1 2025, an estimated $787K.
  • Bridgeway Capital Management first reported a position in NEVRO CORP. in Q3 2024 and held it in 2 quarters.
  • Bridgeway Capital Management's NEVRO CORP. position peaked at $1.38M in Q3 2024.
  • 126 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2025.

Based on Bridgeway Capital Management's 13F filing for Q1 2025, filed 15 May 2025.